Filed: 2/13/2025ACC: 0001395064-25-000026
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $289.04M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$289.04M
Total AUM (reported)
31.42M
Total Shares
Allocation by class
COM$278.20M96.3%
SHS$8.31M2.9%
COM CL A NEW$1.26M0.4%
COM CL A$1.05M0.4%
COMMON STOCK$214.3K0.1%
Portfolio Concentration
Top 3$231.79M80.2%
4–10$54.28M18.8%
11–25$2.97M1.0%
Top 3 weight
80.2%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 31.42M
Sole
Full voting authority
31.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other13
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
HilleVax, Inc.
DFNDShares6.72M
TypeSH
Market value$111.82M
38.69%
Sole
6.72M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares4.21M
TypeSH
Market value$86.48M
29.92%
Sole
4.21M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares3.15M
TypeSH
Market value$33.49M
11.59%
Sole
3.15M
Shared
0.00
None
0.00
Ovid Therapeutics Inc.
DFNDShares7.53M
TypeSH
Market value$22.97M
7.95%
Sole
7.53M
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares1.50M
TypeSH
Market value$13.42M
4.64%
Sole
1.50M
Shared
0.00
None
0.00
Wave Life Sciences Ltd.
DFNDShares1.35M
TypeSH
Market value$8.31M
2.88%
Sole
1.35M
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$4.22M
1.46%
Sole
1.82M
Shared
0.00
None
0.00
Turnstone Biologics Corp.
DFNDShares895.82K
TypeSH
Market value$2.35M
0.81%
Sole
895.82K
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
DFNDShares1.48M
TypeSH
Market value$1.59M
0.55%
Sole
1.48M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
DFNDShares85.84K
TypeSH
Market value$1.42M
0.49%
Sole
85.84K
Shared
0.00
None
0.00
American Well Corp
DFNDShares1.55M
TypeSH
Market value$1.26M
0.44%
Sole
1.55M
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares338.68K
TypeSH
Market value$1.05M
0.36%
Sole
338.68K
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
DFNDShares13.58K
TypeSH
Market value$401.6K
0.14%
Sole
13.58K
Shared
0.00
None
0.00
Akili, Inc.
DFNDShares738.82K
TypeSH
Market value$214.3K
0.07%
Sole
738.82K
Shared
0.00
None
0.00
STANDARD BIOTOOLS INC.
DFNDShares16.52K
TypeSH
Market value$44.8K
0.02%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
HilleVax, Inc.DFND | COM | 6.72M | SH | $111.82M 38.69% | 6.72M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 4.21M | SH | $86.48M 29.92% | 4.21M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 3.15M | SH | $33.49M 11.59% | 3.15M | 0.00 | 0.00 |
Ovid Therapeutics Inc.DFND | COM | 7.53M | SH | $22.97M 7.95% | 7.53M | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 1.50M | SH | $13.42M 4.64% | 1.50M | 0.00 | 0.00 |
Wave Life Sciences Ltd.DFND | SHS | 1.35M | SH | $8.31M 2.88% | 1.35M | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $4.22M 1.46% | 1.82M | 0.00 | 0.00 |
Turnstone Biologics Corp.DFND | COM | 895.82K | SH | $2.35M 0.81% | 895.82K | 0.00 | 0.00 |
Xilio Therapeutics, Inc.DFND | COM | 1.48M | SH | $1.59M 0.55% | 1.48M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.DFND | COM | 85.84K | SH | $1.42M 0.49% | 85.84K | 0.00 | 0.00 |
American Well CorpDFND | COM CL A NEW | 1.55M | SH | $1.26M 0.44% | 1.55M | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM CL A | 338.68K | SH | $1.05M 0.36% | 338.68K | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.DFND | COM | 13.58K | SH | $401.6K 0.14% | 13.58K | 0.00 | 0.00 |
Akili, Inc.DFND | COMMON STOCK | 738.82K | SH | $214.3K 0.07% | 738.82K | 0.00 | 0.00 |
STANDARD BIOTOOLS INC.DFND | COM | 16.52K | SH | $44.8K 0.02% | 16.52K | 0.00 | 0.00 |